CL2019001944A1 - Composición de liberación rápida de cinitaprida y simeticona y proceso para prepararla. - Google Patents

Composición de liberación rápida de cinitaprida y simeticona y proceso para prepararla.

Info

Publication number
CL2019001944A1
CL2019001944A1 CL2019001944A CL2019001944A CL2019001944A1 CL 2019001944 A1 CL2019001944 A1 CL 2019001944A1 CL 2019001944 A CL2019001944 A CL 2019001944A CL 2019001944 A CL2019001944 A CL 2019001944A CL 2019001944 A1 CL2019001944 A1 CL 2019001944A1
Authority
CL
Chile
Prior art keywords
cinitapride
preparing
rapid release
composition
simethicone
Prior art date
Application number
CL2019001944A
Other languages
English (en)
Spanish (es)
Inventor
José Luis Lauria
Original Assignee
Rhein Siegfried Sa De Cv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhein Siegfried Sa De Cv filed Critical Rhein Siegfried Sa De Cv
Publication of CL2019001944A1 publication Critical patent/CL2019001944A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CL2019001944A 2017-02-07 2019-07-11 Composición de liberación rápida de cinitaprida y simeticona y proceso para prepararla. CL2019001944A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2017001714A MX2017001714A (es) 2017-02-07 2017-02-07 Composicion de liberacion rapida de cinitaprida y simeticona y proceso para prepararla.

Publications (1)

Publication Number Publication Date
CL2019001944A1 true CL2019001944A1 (es) 2019-12-06

Family

ID=63108046

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019001944A CL2019001944A1 (es) 2017-02-07 2019-07-11 Composición de liberación rápida de cinitaprida y simeticona y proceso para prepararla.

Country Status (10)

Country Link
AR (1) AR110797A1 (pt)
BR (1) BR112019015989A2 (pt)
CL (1) CL2019001944A1 (pt)
CO (1) CO2019008347A2 (pt)
CR (1) CR20190402A (pt)
DO (1) DOP2019000190A (pt)
EC (1) ECSP19051198A (pt)
MX (1) MX2017001714A (pt)
PE (1) PE20191491A1 (pt)
WO (1) WO2018146575A1 (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6676933B2 (en) * 2001-05-23 2004-01-13 Osmotica Corp. Pharmaceutical composition containing mosapride and pancreatin
EP1596838A2 (en) * 2003-02-11 2005-11-23 Torrent Pharmaceuticals Ltd Once a day orally administered pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
EP1817012A2 (en) * 2004-11-24 2007-08-15 Merck & Co., Inc. Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide
WO2009066146A2 (en) * 2007-11-19 2009-05-28 Cadila Pharmaceuticals Ltd. Stable solutions of sparingly soluble actives

Also Published As

Publication number Publication date
WO2018146575A1 (es) 2018-08-16
AR110797A1 (es) 2019-05-02
DOP2019000190A (es) 2019-10-15
BR112019015989A2 (pt) 2020-03-31
MX2017001714A (es) 2018-08-06
CR20190402A (es) 2019-09-20
ECSP19051198A (es) 2019-07-31
CO2019008347A2 (es) 2019-08-30
PE20191491A1 (es) 2019-10-21

Similar Documents

Publication Publication Date Title
BR112018076601A2 (pt) formulação farmacêutica oral, métodos para tratar um paciente, e, uso de uma formulação
MY187047A (en) Selective pyy compounds and uses thereof
PE20151301A1 (es) Formulaciones farmaceuticas resistentes a la manipulacion indebida
IL274098A (en) GLP-2 analogs and peptidogles for administration before, during or after surgery
EA201792487A1 (ru) Композиции гидроксипропил-бета-циклодекстринов и способы
CL2017001483A1 (es) Formulación de relación fija de insulina glargina/lixisenatida
ECSP16084317A (es) Formulaciones farmacéuticas, procesos para la preparación y métodos de uso
CO6640264A2 (es) Combinación de gránulos cargados activos con activos adicionales
EA201991287A1 (ru) Твердые фармацевтические композиции на основе тикагрелора для перорального применения
BR112018015118A2 (pt) composição farmacêutica injetável inclusiva de trabectedina para uso externo gastrointestinal e método de fabricação da mesma
BR112015022946A2 (pt) forma de dosagem de cápsula de gelatina macia farmacêutica com goma guar modificada
CO2017003913A2 (es) Composición farmacéutica sólida que comprende amlodipino y losartán
CL2019001944A1 (es) Composición de liberación rápida de cinitaprida y simeticona y proceso para prepararla.
ECSP16005208A (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
CL2018002765A1 (es) Proceso de producción de formulaciones sólidas de mesalazina.
CL2019001462A1 (es) Composición mejorada de lansoprazol y simeticona y proceso para prepararla.
CL2017000026A1 (es) Formas de dosificación farmacéutica
CL2019002446A1 (es) Dropropizina en combinación con ambroxol en la forma farmacéutica de jarabe y tabletas.
AR108371A1 (es) Comprimidos de metilfenidato de liberación retardada
ECSP19044926A (es) Composición mejorada de lansoprazol y simeticona y proceso para prepararla
ECSP16086746A (es) Formulación inmunosupresora
UA91282U (uk) Фармацевтичний продукт, що має виражену антигестагенну дію
AR102215A1 (es) Compuesto de pirazol-4-carboxamida, composición farmacéutica que lo comprende y su uso para la fabricación de un medicamento
CU20130165A7 (es) Liberación modificada de 4-metil-3-[[-4-(3- piridinil)-2-pirimidinil]amino]-n-5-(4- metil-1h-imidazol-1- il)-3- (trifluorometil) fenil] benzamida solubilizada utilizando acidos orgánicos
UA97716U (uk) Лікарський засіб у формі сиропу, що містить фенспіриду гідрохлорид